Natus Medical Enterprise Value over EBIT Trend

Natus Medical Incorporated -- USA Stock  

USD 39.9  0.2  0.5%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 142, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 30.0252. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Enterprise Value over EBIT of Natus Medical Incorporated with missing and latest data points interpolated. Measures the ratio between Enterprise Value and Earning Before Interest and Taxes USD.
Enterprise Value over EBIT  10 Years Trend  
Increasing
Stable
 Enterprise Value over EBIT 
      Timeline 

Natus Medical Enterprise Value over EBIT Over Time

2015-12-31  28 
2016-12-31  19 
2017-12-31  24.74 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  19.89
Geometric Mean  22.18
Coefficient Of Variation  123.44
Mean Deviation  14.1
Median  22
Standard Deviation  24.56
Sample Variance  603.12
Range  103
R Value  0.3
Mean Square Error  602.55
R Squared  0.091763
Significance  0.34
Slope  2.06
Total Sum of Squares  6,634

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
2 days ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 117.4